These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 8665356)
21. Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis. Fernández J; Navasa M; Garcia-Pagan JC; G-Abraldes J; Jiménez W; Bosch J; Arroyo V J Hepatol; 2004 Sep; 41(3):384-90. PubMed ID: 15336440 [TBL] [Abstract][Full Text] [Related]
22. Neurohormonal activation, the renal dopaminergic system and sodium handling in patients with severe heart failure under vasodilator therapy. Ferreira A; Bettencourt P; Dias P; Pestana M; Serrão P; Soares-da-Silva P; Cerqueira-Gomes M Clin Sci (Lond); 2001 May; 100(5):557-66. PubMed ID: 11294697 [TBL] [Abstract][Full Text] [Related]
23. Plasma noradrenaline levels in regular haemodialysis patients. Brecht HM; Ernst W; Koch KM Proc Eur Dial Transplant Assoc; 1976; 12():281-90. PubMed ID: 935119 [TBL] [Abstract][Full Text] [Related]
24. Impaired baroreceptor control of renal sympathetic activity in human chronic heart failure. Al-Hesayen A; Parker JD Circulation; 2004 Jun; 109(23):2862-5. PubMed ID: 15173026 [TBL] [Abstract][Full Text] [Related]
25. The effect of varying sodium intake on blood volume, forearm blood flow and vascular responsiveness to sympathetic stimulation in pre-ascitic cirrhosis. Wong F; Logan A; Blendis L Clin Invest Med; 1996 Jun; 19(3):184-94. PubMed ID: 8724822 [TBL] [Abstract][Full Text] [Related]
26. Splanchnic and renal elimination and release of catecholamines in cirrhosis. Evidence of enhanced sympathetic nervous activity in patients with decompensated cirrhosis. Henriksen JH; Ring-Larsen H; Kanstrup IL; Christensen NJ Gut; 1984 Oct; 25(10):1034-43. PubMed ID: 6479678 [TBL] [Abstract][Full Text] [Related]
27. Plasma substance P levels in patients with liver cirrhosis: relationship to systemic and portal hemodynamics. Lee FY; Lin HC; Tsai YT; Chang FY; Lu RH; Hou MC; Li CP; Chu CJ; Wang SS; Lee SD Am J Gastroenterol; 1997 Nov; 92(11):2080-4. PubMed ID: 9362197 [TBL] [Abstract][Full Text] [Related]
28. Inappropriately low angiotensin II generation: a factor determining reduced kidney function and survival in patients with decompensated cirrhosis. Sansoé G; Silvano S; Mengozzi G; Todros L; Smedile A; Touscoz G; Rosina F; Rizzetto M J Hepatol; 2004 Mar; 40(3):417-23. PubMed ID: 15123355 [TBL] [Abstract][Full Text] [Related]
29. Effect of sympathetic and plasma renin activity on hemodialysis hypertension. Grekas D; Kalevrosoglou I; Karamouzis M; Geropoulou E; Kabouris H; Tourkantonis A Clin Nephrol; 2001 Feb; 55(2):115-20. PubMed ID: 11269674 [TBL] [Abstract][Full Text] [Related]
30. Effects of insulin on renal function, sympathetic nervous activity and forearm blood flow in normal human subjects. Wong F; Blendis L; Logan A Clin Invest Med; 1997 Oct; 20(5):344-53. PubMed ID: 9336660 [TBL] [Abstract][Full Text] [Related]
31. Renal functional reserve and nitric oxide in patients with compensated liver cirrhosis. Woitas RP; Heller J; Stoffel-Wagner B; Spengler U; Sauerbruch T Hepatology; 1997 Oct; 26(4):858-64. PubMed ID: 9328305 [TBL] [Abstract][Full Text] [Related]
32. Nitric oxide synthase inhibition does not improve renal function in cirrhotic patients with ascites. Thiesson HC; Skøtt O; Jespersen B; Schaffalitzky de Muckadell OB Am J Gastroenterol; 2003 Jan; 98(1):180-6. PubMed ID: 12526955 [TBL] [Abstract][Full Text] [Related]
33. [Renal and extra-renal mechanisms of sodium and water retention in cirrhosis with ascites]. Peña JC Rev Invest Clin; 1995; 47(1):63-79. PubMed ID: 7777718 [TBL] [Abstract][Full Text] [Related]
34. Relationships between hemodynamic alterations and Child-Pugh Score in patients with cirrhosis. Dincer D; Besisk F; Demirkol O; Demir K; Kaymakoglu S; Cakaloglu Y; Okten A Hepatogastroenterology; 2005; 52(65):1521-5. PubMed ID: 16201110 [TBL] [Abstract][Full Text] [Related]
35. Does endothelin-1 play a role in the renal function of cirrhotic patients? Bruno CM; D'Amico R; Ierna D; Neri S Panminerva Med; 1998 Sep; 40(3):196-8. PubMed ID: 9785916 [TBL] [Abstract][Full Text] [Related]
36. Arachidonic acid derivatives and renal function in liver cirrhosis. Laffi G; La Villa G; Pinzani M; Marra F; Gentilini P Semin Nephrol; 1997 Nov; 17(6):530-48. PubMed ID: 9353864 [TBL] [Abstract][Full Text] [Related]
37. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome. Wong F; Pantea L; Sniderman K Hepatology; 2004 Jul; 40(1):55-64. PubMed ID: 15239086 [TBL] [Abstract][Full Text] [Related]
38. Significance of increased plasma adrenomedullin concentration in patients with cirrhosis. Kojima H; Tsujimoto T; Uemura M; Takaya A; Okamoto S; Ueda S; Nishio K; Miyamoto S; Kubo A; Minamino N; Kangawa K; Matsuo H; Fukui H J Hepatol; 1998 May; 28(5):840-6. PubMed ID: 9625320 [TBL] [Abstract][Full Text] [Related]
39. Time course of changes of plasma renin activity and catecholamines during hemorrhage in conscious sheep. Starc TJ; Stalcup SA Circ Shock; 1987; 21(2):129-40. PubMed ID: 3549039 [TBL] [Abstract][Full Text] [Related]
40. Effects of tilting on central hemodynamics and homeostatic mechanisms in cirrhosis. Møller S; Nørgaard A; Henriksen JH; Frandsen E; Bendtsen F Hepatology; 2004 Oct; 40(4):811-9. PubMed ID: 15382169 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]